Can a smartphone app ease cancer Survivors' stress? new trial aims to find out

NCT ID NCT05470010

First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 4 times

Summary

This study tests whether a smartphone app that teaches mindfulness can help reduce stress in people who have finished cancer treatment. About 345 cancer survivors will be randomly assigned to use the app right away or wait three months. The goal is to see if the app makes a real difference in how stressed they feel.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
smartphone app-based mindfulness intervention (Mindfulness-Based Cancer Survivorship Journey app)
What this could lead to
If it works, this could offer a safe, accessible way for cancer survivors to manage stress and improve well-being after treatment.
What could go wrong
This is a behavioral intervention, not a medical treatment. Results depend on participants' commitment to daily practice, and the app may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Arthur J.E. Child Comprehensive Cancer Centre

    Calgary, Alberta, T2N 5G2, Canada

  • BCCA - Kelowna

    Kelowna, British Columbia, V1Y 5L3, Canada

  • BCCA - Prince George

    Prince George, British Columbia, V2M 7E9, Canada

  • BCCA - Victoria

    Victoria, British Columbia, V8R 6V5, Canada

  • Horizon Health Network

    Fredericton, New Brunswick, E3B 5N5, Canada

  • Kingston Health Sciences Centre

    Kingston, Ontario, K7L 2V7, Canada

  • Western Manitoba Cancer Centre

    Brandon, Manitoba, R7A 2B3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.